713 related articles for article (PubMed ID: 17667864)
1. The endocannabinoid system: a new target for the regulation of energy balance and metabolism.
Després JP
Crit Pathw Cardiol; 2007 Jun; 6(2):46-50. PubMed ID: 17667864
[TBL] [Abstract][Full Text] [Related]
2. Endocannabinoid control of food intake and energy balance.
Di Marzo V; Matias I
Nat Neurosci; 2005 May; 8(5):585-9. PubMed ID: 15856067
[TBL] [Abstract][Full Text] [Related]
3. Photoperiodic changes in endocannabinoid levels and energetic responses to altered signalling at CB1 receptors in Siberian hamsters.
Ho JM; Smith NS; Adams SA; Bradshaw HB; Demas GE
J Neuroendocrinol; 2012 Jul; 24(7):1030-9. PubMed ID: 22420341
[TBL] [Abstract][Full Text] [Related]
4. Contribution of CB1 blockade to the management of high-risk abdominal obesity.
Després JP; Lemieux I; Alméras N
Int J Obes (Lond); 2006 Apr; 30 Suppl 1():S44-52. PubMed ID: 16570106
[TBL] [Abstract][Full Text] [Related]
5. The endocannabinoid system and the treatment of obesity.
Pagotto U; Vicennati V; Pasquali R
Ann Med; 2005; 37(4):270-5. PubMed ID: 16019725
[TBL] [Abstract][Full Text] [Related]
6. Cocaine- and amphetamine-related transcript is involved in the orexigenic effect of endogenous anandamide.
Osei-Hyiaman D; Depetrillo M; Harvey-White J; Bannon AW; Cravatt BF; Kuhar MJ; Mackie K; Palkovits M; Kunos G
Neuroendocrinology; 2005; 81(4):273-82. PubMed ID: 16131814
[TBL] [Abstract][Full Text] [Related]
7. The endocannabinoid system: a promising target for the management of type 2 diabetes.
Scheen AJ
Curr Protein Pept Sci; 2009 Feb; 10(1):56-74. PubMed ID: 19275673
[TBL] [Abstract][Full Text] [Related]
8. Feeding disorders and obesity.
Cervino C; Vicennati V; Pasquali R; Pagotto U
Curr Top Behav Neurosci; 2009; 1():373-85. PubMed ID: 21104392
[TBL] [Abstract][Full Text] [Related]
9. Role of the endocannabinoid system in energy balance regulation and obesity.
Cota D
Front Horm Res; 2008; 36():135-145. PubMed ID: 18230900
[TBL] [Abstract][Full Text] [Related]
10. Role of the endocannabinoid system in management of patients with type 2 diabetes mellitus and cardiovascular risk factors.
Davis SN; Perkins JM
Endocr Pract; 2007; 13(7):790-804. PubMed ID: 18194939
[TBL] [Abstract][Full Text] [Related]
11. The endocannabinoid system and cardiometabolic risk: effects of CB1 receptor blockade on lipid metabolism.
Deedwania P
Int J Cardiol; 2009 Jan; 131(3):305-12. PubMed ID: 18715660
[TBL] [Abstract][Full Text] [Related]
12. A peripheral mechanism for CB1 cannabinoid receptor-dependent modulation of feeding.
Gómez R; Navarro M; Ferrer B; Trigo JM; Bilbao A; Del Arco I; Cippitelli A; Nava F; Piomelli D; Rodríguez de Fonseca F
J Neurosci; 2002 Nov; 22(21):9612-7. PubMed ID: 12417686
[TBL] [Abstract][Full Text] [Related]
13. [Impact of endocannabinoid system in modulation of cardiometabolic risk factors].
Sulcová A
Vnitr Lek; 2006 Jun; 52(6):615-8. PubMed ID: 16871766
[TBL] [Abstract][Full Text] [Related]
14. The endocannabinoid system as a novel approach for managing obesity.
Lillo JL
J Am Osteopath Assoc; 2007 Apr; 107(4 Suppl 2):S12-20. PubMed ID: 17784530
[TBL] [Abstract][Full Text] [Related]
15. The challenge of treating obesity: the endocannabinoid system as a potential target.
Isoldi KK; Aronne LJ
J Am Diet Assoc; 2008 May; 108(5):823-31. PubMed ID: 18442506
[TBL] [Abstract][Full Text] [Related]
16. Understanding metabolic homeostasis and imbalance: what is the role of the endocannabinoid system?
Kunos G
Am J Med; 2007 Sep; 120(9 Suppl 1):S18-24; discussion S24. PubMed ID: 17720356
[TBL] [Abstract][Full Text] [Related]
17. New vistas for treatment of obesity and diabetes? Endocannabinoid signalling and metabolism in the modulation of energy balance.
Lipina C; Rastedt W; Irving AJ; Hundal HS
Bioessays; 2012 Aug; 34(8):681-91. PubMed ID: 22674489
[TBL] [Abstract][Full Text] [Related]
18. Additive actions of the cannabinoid and neuropeptide Y systems on adiposity and lipid oxidation.
Zhang L; Lee NJ; Nguyen AD; Enriquez RF; Riepler SJ; Stehrer B; Yulyaningsih E; Lin S; Shi YC; Baldock PA; Herzog H; Sainsbury A
Diabetes Obes Metab; 2010 Jul; 12(7):591-603. PubMed ID: 20590734
[TBL] [Abstract][Full Text] [Related]
19. Role of the endocannabinoid system in metabolic control.
Wang J; Ueda N
Curr Opin Nephrol Hypertens; 2008 Jan; 17(1):1-10. PubMed ID: 18090663
[TBL] [Abstract][Full Text] [Related]
20. [The endocannabinoid system].
Sudano I; Périat D; Noll G
Praxis (Bern 1994); 2008 Apr; 97(7):375-80. PubMed ID: 18548817
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]